Polyphosphazene-Based Nanotherapeutics
Source abstract
Abstract
Poly(organo)phosphazenes (PPZs) are increasingly recognized as versatile biomaterials for drug delivery applications in nanomedicine. Their unique hybrid structure—featuring an inorganic backbone and highly tunable organic side chains—confers exceptional biocompatibility and adaptability. Through precise synthetic methodologies, PPZs can be engineered to exhibit a wide spectrum of functional properties, including the formation of multifunctional nanostructures tailored for specific therapeutic needs. These attributes enable PPZs to address several critical challenges associated with conventional drug delivery systems, such as poor pharmacokinetics and pharmacodynamics. By modulating solubility profiles, enhancing drug stability, enabling targeted delivery, and supporting controlled release, PPZs offer a robust platform for improving therapeutic efficacy and patient outcomes. This review explores the fundamental chemistry, biopharmaceutical characteristics, and biomedical applications of PPZs, particularly emphasizing their role in zero-dimensional nanotherapeutic systems, including various nanoparticle formulations. PPZ-based nanotherapeutics are further examined based on their drug-loading mechanisms, which include electrostatic complexation in polyelectrolytic systems, self-assembly in amphiphilic constructs, and covalent conjugation with active pharmaceutical agents. Together, these strategies underscore the potential of PPZs as a next-generation material for advanced drug delivery platforms.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Flame retardant materials and properties · Synthesis and properties of polymers · biodegradable polymer synthesis and properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacology, Pharmacy and Pharmaceutical Technology, CiMUS Research Centre, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
Fundation Institute of Health Research of Santiago (FIDIS), 15706 Santiago de Compostela, Spain
Funding
Ministerio de Ciencia e Innovación (MCIN), Agencia Estatal de Investigación (AEI), and European Regional Development Fund (ERDF) · Health Institute Carlos III (ICIII), MCIN and AEI · Ministerio de Educación y Formación Profesional
References (100+)
Show source-provided references
1. Minko, T., Khandare, J.J., Vetcher, A.A., Soldatenkov, V.A., Garbuzenko, O.B., Saad, M., and Pozharov, V.P. (2008). Multifunctional Nanotherapeutics for Cancer. Multifunctional Pharmaceutical Nanocarriers, Springer Nature.10.1007/978-0-387-76554-9_10 ↗
2. Nanotherapeutics in the EU: An Overview on Current State and Future Directions10.2147/IJN.S55359 ↗
3. Andrianov, A.K. (2009). Polyphosphazenes for Biomedical Applications, Wiley.10.1002/9780470478882 ↗
4. Poly(organophosphazene)s and Related Compounds: Synthesis, Properties and Applications10.1016/S0079-6700(97)00027-0 ↗
5. Phosphazene Cyclomatrix Network-Based Polymer: Chemistry, Synthesis, and Applications10.1021/acsomega.2c01573 ↗
6. Polyphosphazenes: Multifunctional, Biodegradable Vehicles for Drug and Gene Delivery10.3390/polym5010161 ↗
7. Poly(organophosphazenes): Synthesis, Unique Properties, and Applications10.1002/masy.19860060112 ↗
8. Recent Research Progress on Polyphosphazene-Based Drug Delivery Systems10.1039/C9TB02517K ↗
9. Generational Biodegradable and Regenerative Polyphosphazene Polymers and Their Blends with poly (lactic-co-glycolic acid)10.1016/j.progpolymsci.2019.101146 ↗
10. COBRA PzFTM Coronary Stent in Clinical and Preclinical Studies: Setting the Stage for New Antithrombotic Strategies?10.2217/fca-2021-0057 ↗
11. Biodegradable Polymers II. Degradation Characteristics of Hydrolysis-Sensitive Poly[(Organo)Phosphazenes]10.1016/0142-9612(92)90028-M ↗
12. Smart and Genetically Engineered Biomaterials and Drug Delivery Systems10.1016/S0928-0987(03)00164-7 ↗
13. Biodegradable Polyphosphazenes for Drug Delivery Applications10.1016/S0169-409X(03)00039-5 ↗
14. Biodegradable Polyphosphazene-Based Blends for Regenerative Engineering10.1007/s40883-016-0022-7 ↗
15. Effect of Side Group Chemistry on the Properties of Biodegradable -Alanine Cosubstituted Polyphosphazenes10.1021/bm050752r ↗
16. PCPP as a Parenteral Adjuvant for Diverse Antigens
17. Kumbar, S.G., Laurencin, C.T., and Deng, M. (2014). Polyphosphazenes. Naturals and Synthetic Biomedical Polymers, Elsevier.
18. Nanoparticles in Modern Medicine: State of the Art and Future Challenges
19. Small-Scale Big Science: From Nano- to Atomically Dispersed Catalytic Materials10.1002/smsc.202200036 ↗
20. Water-Soluble Cationic Polyphosphazenes Grafted with Cyclic Polyamine and Imidazole as an Effective Gene Delivery Vector10.1021/acs.bioconjchem.6b00048 ↗
21. Structure-Optimized Interpolymer Polyphosphazene Complexes for Effective Gene Delivery against Glioblastoma10.1002/adtp.201800126 ↗
22. Garcia-Mazas, C., Bozzato, E., Araujo Fernandez, J.A., Quattrini, F., Preat, V., Sanchez, L., Csaba, N., and Garcia-Fuentes, M. (2025). Designing Polyphosphazene Derivatives for Gene Delivery in Glioblastoma Treatment. Mater. Today Bio, 33.10.1016/j.mtbio.2025.102010 ↗
23. Amphiphilic Polymers Formed from Ring-Opening Polymerization: A Strategy for the Enhancement of Gene Delivery10.1039/C6BM00859C ↗
24. Development of Cholate Conjugated Hybrid Polymeric Micelles for FXR Receptor Mediated Effective Site-Specific Delivery of Paclitaxel10.1039/C8NJ03251C ↗
25. Thermosensitive Micelles Self-Assembled by Novel N-Isopropylacrylamide Oligomer Grafted Polyphosphazene10.1002/marc.200400180 ↗
26. Synthesis of Polyorganophosphazenes and Preparation of Their Polymersomes for Reductive/Acidic Dual-Responsive Anticancer Drugs Release10.1007/s10853-020-04595-6 ↗
27. Kuperkar, K., Patel, D., Atanase, L.I., and Bahadur, P. (2022). Amphiphilic Block Copolymers: Their Structures, and Self-Assembly to Polymeric Micelles and Polymersomes as Drug Delivery Vehicles. Polymers, 14.10.3390/polym14214702 ↗
28. In Situ Generated Gold Nanoparticle Hybrid Polymersomes for Water-Soluble Chemotherapeutics: Inhibited Leakage and PH-Responsive Intracellular Release10.1002/adfm.201604981 ↗
29. Synthesis and Properties of a New Micellar Polyphosphazene-Platinum (II) Conjugate Drug10.1016/j.jinorgbio.2014.06.014 ↗
30. Design of Theranostic Nanomedicine (Ii): Synthesis and Physicochemical Properties of a Biocompatible Polyphosphazene–Docetaxel Conjugate10.2147/IJN.S140073 ↗
31. Design of a Novel Theranostic Nanomedicine (Iii): Synthesis and Physicochemical Properties of Tumor-Targeting Cisplatin Conjugated to a Hydrophilic Polyphosphazene10.2147/IJN.S235618 ↗
32. Gleria, M., and De Jaeger, R. (2004). Phosphazenes: A Worldwide Insight, Nova Publishers.
33. Allcock, H.R. (2003). Chemistry and Applications of Polyphosphazenes, Wiley-Interscienc.
34. Polydichlorophosphazene Polymerization Studies10.1080/00222338108082058 ↗
35. Polymeric Materials Based on Main Group Elements: The Recent Development of Ambient Temperature and Controlled Routes to Polyphosphazenes10.1039/b719361k ↗
36. Synthesis of Poly(dichlorophosphazene) by the Melt Phase Polymerization of P-Trichloro-N-(Dichlorophosphoryl)Monophosphazene10.1007/s10904-017-0516-x ↗
37. Poly(dichlorophosphazene) from p-trichloro-n-dichlorophosphoryl monophosphazene Cl3P=N-POCl2
38. A New Route to the Phosphazene Polymerization Precursors, Cl3P=NSiMe3 and (NPCl2)310.1021/ic980534p ↗
39. “Living” Cationic Polymerization of Phosphoranimines as an Ambient Temperature Route to Polyphosphazenes with Controlled Molecular Weights10.1021/ma960876j ↗
40. Influence of Reaction Parameters on the Living Cationic Polymerization of Phosphoranimines to Polyphosphazenes10.1021/ma000574o ↗
41. The Coordination Chemistry of Group 15 Element Ligand Complexes–A Developing Area10.1039/b718179p ↗
42. Probing the Mechanism of the PCl5-Initiated Living Cationic Polymerization of the Phosphoranimine Cl3P=NSiMe3 Using Model Compound Chemistry10.1021/ja808517d ↗
43. A Cooperative Role for the Counteranion in the PCl5-Initiated Living, Cationic Chain Growth Polycondensation of the Phosphoranimine Cl3P=NSiMe310.1021/ja307703h ↗
44. Branched Polyphosphazenes with Controlled Dimensions10.1002/pola.26865 ↗
45. Poly(dichlorophosphazene) as a Precursor for Biologically Active Polyphosphazenes: Synthesis, Characterization, and Stabilization10.1021/ma0355655 ↗
46. Hosmane, N.S. (2021). Synthetic Inorganic Chemistry–New Perspectives, Elsevier.
47. Open-Chain Poly(organophosphazenes)
48. Synthesis, Structures, and Emerging Uses for Poly(organophosphazenes)10.1021/bk-2018-1298.ch001 ↗
49. Metal-Containing Poly(organophosphazenes)10.1002/masy.200650313 ↗
50. The Synthesis of Functional Polyphosphazenes and Their Surfaces10.1002/(SICI)1099-0739(199810/11)12:10/11<659::AID-AOC773>3.0.CO;2-2 ↗
51. Unichemo Protection: A Concept for Chemical Synthesis10.1002/1521-3773(20011001)40:19<3655::AID-ANIE3655>3.0.CO;2-K ↗
52. Andrianov, K.A. (2008). Polyphosphazenes from Condensation Polymerization. Polyphosphazenes for Biomedical Applications, Wiley.10.1002/9780470478882 ↗
53. Hydrolysis Pathways for Aminophosphazenes10.1021/ic00132a009 ↗
54. Degradation of Polyaminophosphazenes: Effects of Hydrolytic Environment and Polymer Processing10.1021/bm050959k ↗
55. Glyceryl Polyphosphazenes: Synthesis, Properties, and Hydrolysis10.1021/ma00185a015 ↗
56. Polyphosphazenes with Glucosyl and Methylamino, Trifluoroethoxy, Phenoxy, or (Methoxyethoxy)Ethoxy Side Groups10.1021/ma00001a005 ↗
57. Synthesis of Poly(orgnaophosphazenes) with Glycolic Acid Ester and Lactic Acid Ester Side Groups: Prototypes for New Bioerodible Polymers10.1021/ma00079a001 ↗
58. Biodegradable Polyphosphazene Biomaterials for Tissue Engineering and Delivery of Therapeutics10.1155/2014/761373 ↗
59. Controlled Release Using a New Bioerodible Polyphosphazene Matrix System10.1002/jbm.820211006 ↗
60. Degradable Polyphosphazene/Poly(a-Hydroxyester) Blends: Degradation Studies10.1016/S0142-9612(01)00293-9 ↗
61. Acid-Responsive and Biologically Degradable Polyphosphazene Nanodrugs for Efficient Drug Delivery10.1021/acsbiomaterials.0c00378 ↗
62. Synthesis and In Vivo Anticancer Evaluation of Poly(organo)Phosphazene-Based Metallodrug Conjugates10.1039/C7DT01767G ↗
63. A PH-sensitive Macromolecular Prodrug as TLR7/8 Targeting Immune Response Modifier10.1002/chem.201702942 ↗
64. Stimuli-Responsive Phosphorus-Based Polymers10.1002/ejic.201801077 ↗
65. Dual-Responsive Polyphosphazene as a Common Platform for Highly Efficient Drug Self-Delivery10.1039/C9TB00801B ↗
66. Oxidation Responsive Polymers with a Triggered Degradation via Arylboronate Self-Immolative Motifs on a Polyphosphazene Backbone10.1021/acsmacrolett.7b00015 ↗
67. Degradable, Dendritic Polyols on a Branched Polyphosphazene Backbone10.1021/acs.iecr.7b05301 ↗
68. Dual Stimuli-Responsive Polyphosphazene-Based Molecular Gates for Controlled Drug Delivery in Lung Cancer Cells10.1039/D0RA03210G ↗
69. Synthesis of Polyphosphazenes with Different Side Groups and Various Tactics for Drug Delivery10.1039/C6RA27103K ↗
70. Coumarin-Caged Polyphosphazenes with a Visible-Light Driven On-Demand Degradation10.1002/marc.201800377 ↗
71. Applicability of New Degradable Hypericin-Polymer-Conjugates as Photosensitizers: Principal Mode of Action Demonstrated by in Vitro Models10.1039/c4pp00251b ↗
72. Report on the Use of Poly(organophosphazenes) for the Design of Stimuli-Responsive Vesicles10.1021/bm0400527 ↗
73. Polyelectrolyte Complex for Drug Delivery in Biomedical Applications: A Review10.1088/1757-899X/1183/1/012007 ↗
74. Polyelectrolyte-Based Platforms for the Delivery of Peptides and Proteins10.1021/acsbiomaterials.9b01135 ↗
75. Nanocarriers: Promising Vehicle for Bioactive Drugs10.1248/bpb.29.1790 ↗
76. Vasile, C. (2018). Polymeric Nanomaterials: Recent Developments, Properties and Medical Applications. Polymeric Nanomaterials in Nanotherapeutics, Elsevier.10.1016/B978-0-12-813932-5.00001-7 ↗
77. Polyphosphazene Polyelectrolytes: A Link between the Formation of Noncovalent Complexes with Antigenic Proteins and Immunostimulating Activity10.1021/bm049329t ↗
78. In Vivo Tumor Transfection Mediated by Polyplexes Based on Biodegradable Poly(DMAEA)-Phosphazene10.1016/j.jconrel.2005.05.030 ↗
79. Biodegradable “Smart” Polyphosphazenes with Intrinsic Multifunctionality as Intracellular Protein Delivery Vehicles10.1021/acs.biomac.7b00537 ↗
80. Polyionic Vaccine Adjuvants: Another Look at Aluminum Salts and Polyelectrolytes10.7774/cevr.2015.4.1.23 ↗
81. Water-Soluble Biodegradable Cationic Polyphosphazenes for Gene Delivery10.1016/S0168-3659(03)00127-5 ↗
82. Degradable PEG-Folate Coated Poly(DMAEA-Co-BA) Phosphazene-Based Polyplexes Exhibit Receptor-Specific Gene Expression10.1016/j.ejps.2007.12.003 ↗
83. Hydrolytically Degradable PEGylated Polyelectrolyte Nanocomplexes for Protein Delivery10.1021/acs.biomac.8b00785 ↗
84. Galactosylated Poly(2-(2-Aminoethyoxy)Ethoxy)Phosphazene/DNA Complex Nanoparticles: In Vitro and in Vivo Evaluation for Gene Delivery10.1021/bm901346m ↗
85. Poly[Di(Carboxylatophenoxy)Phosphazene] (PCPP) Is a Potent Immunoadjuvant for an Influenza10.1016/S0264-410X(97)00149-7 ↗
86. Magiri, R.B., Lai, K.J., Mutwiri, G.K., and Wilson, H.L. (2020). Experimental PCEP-Adjuvanted Swine Influenza H1N1 Vaccine Induced Strong Immune Responses but Did Not Protect Piglets against Heterologous H3N2 Virus Challenge. Vaccines, 8.10.3390/vaccines8020235 ↗
87. Molecular-Level Interactions of Polyphosphazene Immunoadjuvants and Their Potential Role in Antigen Presentation and Cell Stimulation10.1021/acs.biomac.6b01251 ↗
88. The Effect of Stable Macromolecular Complexes of Ionic Polyphosphazene on HIV Gag Antigen and on Activation of Human Dendritic Cells and Presentation to T-Cells10.1016/j.biomaterials.2014.06.043 ↗
89. Romanyuk, A., Wang, R., Marin, A., Janus, B.M., Felner, E.I., Xia, D., Goez-Gazi, Y., Alfson, K.J., Yunus, A.S., and Toth, E.A. (2022). Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge. J. Funct. Biomater., 14.10.3390/jfb14010016 ↗
90. Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial with ALVAC-HIV (VCP205) and Oligomeric Glycoprotein 160 from HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene10.1093/infdis/jiw059 ↗
91. In Vivo and In Vitro Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly10.1021/acs.molpharmaceut.0c00487 ↗
92. Next Generation Polyphosphazene Immunoadjuvant: Synthesis, Self-Assembly and in Vivo Potency with Human Papillomavirus VLPs-Based Vaccine10.1016/j.nano.2021.102359 ↗
93. Protein-Loaded Soluble and Nanoparticulate Formulations of Ionic Polyphosphazenes and Their Interactions on Molecular and Cellular Levels10.1016/j.msec.2019.110179 ↗
94. Sustained Release of Exendin 4 Using Injectable and Ionic-Nano-Complex Forming Polymer Hydrogel System for Long-Term Treatment of Type 2 Diabetes Mellitus10.1021/acsami.8b19669 ↗
95. Polymeric Delivery Systems for Nucleic Acid Therapeutics: Approaching the Clinic10.1016/j.jconrel.2021.01.014 ↗
96. Side-Effects of a Systemic Injection of Linear Polyethylenimine-DNA Complexes10.1002/jgm.237 ↗
97. Biodegradable Nanoparticles for Drug and Gene Delivery to Cells and Tissue10.1016/S0169-409X(02)00228-4 ↗
98. Spain, S.G., Yasayan, G., Soliman, M., Heath, F., Saeed, A., and Alexander, C. (2011). Nanoparticles for Nucleic Acid Delivery. Comprehensive Biomaterials, Elsevier.10.1016/B978-0-08-055294-1.00133-1 ↗
99. Biodegradable Poly(2-Dimethylamino Ethylamino)Phosphazene for in Vivo Gene Delivery to Tumor Cells. Effect of Polymer Molecular Weight10.1007/s11095-007-9299-z ↗
100. Poly(Imidazole/DMAEA)Phosphazene/DNA Self-Assembled Nanoparticles for Gene Delivery: Synthesis and in Vitro Transfection10.1016/j.jconrel.2008.01.012 ↗